Therapeutic plasmapheresis in patients with severe hyperthyroidism in whom antithyroid drugs are contraindicated

International Journal of Clinical Practice

Volumn 58, Issue 6, 2004, Pages 554-558

  Ozbey, N ^a,b   Kalayoglu Besisik, S ^a   Gul, N ^a   Bozbora, A ^a   Sencer, E ^a   Molvalilar, S ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Coagulopathy; Hyperthyroidism; Plasmapheresis

Indexed keywords

ANTITHYROID AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; COLESTYRAMINE; FRESH FROZEN PLASMA; GLUCOCORTICOID; HUMAN ALBUMIN; IODINE; LIOTHYRONINE; POTASSIUM IODIDE; PROPRANOLOL; PROPYLTHIOURACIL; THIAMAZOLE; THYROTROPIN; THYROXINE;

ADULT; AGRANULOCYTOSIS; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; BLOOD TRANSFUSION; CASE REPORT; COLLOID; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG ERUPTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GRAVES DISEASE; HOSPITAL ADMISSION; HUMAN; HYPERTHYROIDISM; MALE; MEDICAL DECISION MAKING; PLASMAPHERESIS; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE CARE; PRIORITY JOURNAL; SUBTOTAL THYROIDECTOMY; TREATMENT OUTCOME; URTICARIA; VASCULITIS;

ADULT; ANTITHYROID AGENTS; FEMALE; HUMANS; HYPERTHYROIDISM; MALE; MIDDLE AGED; PLASMAPHERESIS;

EID: 3242880510     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1368-5031.2004.00140.x     Document Type: Article

References (29)

1. Enghofer M, Badenhoop K, Zeuzem S et al. Fulminant hepatitis A in a patient with severe hyperthyroidism: rapid recovery from hepatic coma after plasmapheresis and total thyroidectomy. J Clin Endocrinol Metab 2000; 85: 1765-9.
2. Schlienger JL, Faradji A, Sapin R et al. Treatment of severe hyperthyroidism by plasma exchange. Clinical and biological efficacy. 8 cases. Press Med 1985; 14: 271-1274.
3. Ashkar FS, Katims RB, Smoak WM, Gilson J. Thyroid storm treatment with blood exchange and plasmapheresis. JAMA 1970; 214: 1275-9.
4. De Rosa G, Testa A, Menichella G et al. Plasmapheresis in the therapy of hyperthyroidism associated with leukopenia. Haematologica 1991; 76 (Suppl. 1): 72-4.
5. Braithwaite SS, Brooks MS, Collins S, Bermes EW. Plasmapheresis: an adjunct to medical management of severe hyperthyroidism. J Clin Apheresis 1986; 3: 119-23.
6. Glinoer D, Etienne-Decerf J, Schrooyen M et al. Beneficial effects of intensive plasma exchange followed by immunosuppressive therapy in severe Graves' ophthalmopathy. Acta Endocrinol.1986; 111: 30-8.
7. Bartalena L, Marcocci C, Pinchera A. Treating severe Graves' ophthalmopathy. Baillieres Clin Endocrinol Metab 1997; 11: 521-36.
8. Boers PM, Colebatch JG. Hashimoto's encephalopathy responding to plasmapheresis. J Neurol Neurosurg Psychiatry 2001; 70: 132-41.
9. Robbins J. Thyroid hormone transport proteins and the physiology of hormone binding. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's the Thyroid. A Fundamental and Clinical Text, 8th edn. Philadelphia: Lippincott Williams & Wilkins 2000, 106-20.
10. Lazarus EF, Mein HG. Hemapheresis and cellular theraphy. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, McGlave P, eds. Hematology Basic Principles and Practice, 3rd edn. Philadelphia: Churchill Livingstone, 2000: 2291-300.
11. Schroeder ML. Principles and practice of transfusion medicine. Therapeutic apheresis. In: Lee GR, Foerster J, Lukens J, Paraskevas F, Greer JP, Rodgers GM, eds. Wintrobe's Clinical Hematology, 10th edn. Baltimore: William & Wilkins, 1999: 861-74.
12. Yeh JH, Chiu HC. Coagulation abnormalities in serial double-filtration plasmapheresis. J Clin Apheresis 2001; 16: 139-42.
13. Wood L, Jacops P. The effect of serial therapeutic plasmapheresis on platelet count, coagulation factors, plasma immunoglobulin and complement levels. J Clin Apheresis 1986; 3: 124-8.
14. Orlin JB, Berkman EM. Partial plasma exchange using albumin replacement. Removal and recovery of normal plasma constituents. Blood 1980; 56: 1055-9.
15. Flaum MA, Cuneo RA, Appelbaum FR et al. The hemostatic imbalance of plasma-exchange transfusions. Blood 1979; 54: 695-702.
16. Francis CW, Kaplan KL. Hematologic problems in the surgical patient: bleeding and thrombosis. In: Hoffman R, Benz, EJ Jr, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, McGlave P, eds. Hematology Basic Principles and Practice, 3rd edn. Philadelphia: Churchill Livingstone, 2000: 2381-91.
17. Langley RW, Burch HB. Perioperative management of the thyrotoxic patient. Endocrinol Metab Clin North Am 2003; 32: 519-34.
18. Baeza A, Aguayo J, Barria M, Pineda G. Rapid preoperative preparation in hyperthyroidism. Clin Endocrinol 1991; 35: 439-42.
19. Bogazzi F, Miccoli P, Berri P et al. Preparation with iopanoic acid rapidly controls thyrotoxicosis in patients with amiodarone-induced thyrotoxicosis before thyroidectomy. Surgery 2002; 132: 1114-7.
20. Mochinaga N, Eto T, Maekawa Y et al. Successful preoperative preparation for thyroidectomy in Graves' disease using lithium alone: report of two cases. Surg Today 1994; 24: 464-7.
21. Lennquist S, Jortso E, Andenberg B, Smeds S. Beta blockers compared with antithyroid drugs as preoperative treatment in hyperthyrodism: drug tolerance, complications and postoperative thyroid function. Surgery 1985; 98: 1141-7.
22. Reed J, Bradley EL III. Postoperative thyroid storm after lithium preparation. Surgery 1985; 98: 983-6.
23. Peden NR, Browning MC, Feely J et al. The clinical and metabolic responses to early surgical treatment for hyperthyroid Graves' disease: a comparison of three pre-operative treatment regimens. Q J Med 1985; 56: 579-91.
24. Feely J, Crooks J, Forrest AL et al. Propranolol in the surgical treatment of hyperthyroidism, including severely thyrotoxic patients. Br J Surg 1981; 68: 865-9.
25. Franklyn JA. Management guidelines for hyperthyroidism. Bailliere's Clin Endocrinol Metab 1997; 11: 561-84.
26. Shiran A, Shechner C, Dicksen G. Propylthiouracil-induced agranulocytosis in four patients previously treated with the drug. JAMA 1991; 266: 3129-30.
27. Toth EL, Mant MJ, Shihvi S, Ginsberg J. Propylthiouracil-induced agranulocytosis: an unusual presentation and a possible mechanism. Am J Med 1988; 85: 725-7.
28. Akamizu T, Ozaki S, Hiratani H et al. Drug-induced neutropenia associated with anti-neutrophil cytoplasmic antibodies (ANCA); possible involvement of complement in granulocyte toxicity. Clin Exp Immunol 2002; 127: 92-8.
29. Mercado M, Mendoza-Zubieta V, Bautista-Osorio R, Espinoza-De Los Monteros AL. Treatment of hyperthyroidism with a combination of methimazole and cholestyramine. J Clin Endocrinol Metab 1996; 81: 3191-3.